📋
What It Does
SB 1047 makes two targeted changes to California's existing neurodegenerative disease data collection program: it adds frontotemporal degeneration (FTD) and 'other dementias' to the mandatory list of diseases that must be reported, and it extends the program's sunset date by two years. The program requires hospitals, clinics, and physicians to report every diagnosed or treated case of a covered neurodegenerative disease to the California Department of Public Health.
Adds frontotemporal degeneration (FTD) and other dementias to the statutory list of neurodegenerative diseases subject to mandatory reporting (amending Health & Safety Code §103871(i))
Changes the disease definition language from 'may include, but need not be limited to' to 'includes, but is not limited to' — making the listed diseases mandatory rather than discretionary inclusions
Extends the program's expiration (sunset) from January 1, 2028 to January 1, 2030 (amending §103871.2)
All other existing program mechanics remain unchanged: mandatory provider reporting, CDPH website notification, 90-day advance notice to provider associations, $500/day civil penalty for willful record access refusal, and confidentiality protections
✅
Who Benefits
Patients with FTD and lesser-known dementias — their conditions will now be systematically tracked, improving epidemiological data that can drive research funding and treatment development
Researchers and public health agencies — broader, more consistent disease incidence data across a larger category of neurodegenerative conditions
Advocacy organizations for FTD and dementia patients — formal recognition in state law raises the profile of these conditions
Future patients — two more years of registry data improves long-term disease surveillance and potentially informs policy interventions
California Department of Public Health — clearer statutory mandate removes ambiguity about which diseases must be designated for reporting
⚠️
Who Gets Hurt
Hospitals, outpatient clinics, and physician practices — expanded reporting obligations increase administrative burden, particularly for providers who treat high volumes of dementia patients
Providers who currently under-report or don't report — the tightened 'includes, but is not limited to' language removes a potential legal argument that designation of specific diseases was discretionary
State General Fund — the program has a fiscal committee designation, meaning costs are expected; contract awards under the program are exempted from standard competitive bidding requirements (Public Contract Code Part 2), reducing cost controls
🔍
Hidden Riders
Contract awards for program implementation are exempt from Public Contract Code Part 2 (competitive bidding) — this exemption was already in existing law and is carried forward without scrutiny, meaning the department can award program contracts without standard competitive procurement oversight
The shift from 'may include, but need not be limited to' to 'includes, but is not limited to' in the disease definition is a substantive legal change not highlighted in the digest title — it converts the listed diseases from illustrative examples to mandatory minimums, which expands reporting obligations beyond what the headline change (adding FTD) suggests
🎭
Framing Analysis
Framed as a narrow technical extension and disease-list update — largely accurate; the bill is genuinely limited in scope with no significant policy reversals or hidden expansions beyond the definitional language shift noted above
The bill's title emphasizes 'registry program' generically — the more consequential change may be the definitional tightening ('includes' vs. 'may include'), which is not surfaced in the title or digest summary and affects all currently listed diseases, not just FTD
🚩
Red Flags
⚑Two-year sunset extension rather than permanent authorization — the program has now been extended at least once, suggesting the Legislature is not confident enough in it to make it permanent, leaving stakeholders and CDPH in a recurring state of uncertainty about the program's future
⚑'Other dementias' is not defined — the phrase is added to the mandatory list without statutory definition, leaving CDPH discretion to designate (or not designate) an undefined category of conditions, which could create reporting inconsistency across providers
⚑Program is contingent on funding availability ('implemented only to the extent funds are made available') — even with expanded mandatory reporting, there is no funding guarantee, meaning the mandate could exist on paper while the department lacks resources to actually collect or use the data
⚑No enforcement mechanism beyond the existing $500/day civil penalty for record access refusal — there is no penalty specified for failure to report in the first place (only for failure to grant access after a follow-up request), which is a significant compliance gap
⚑Contract exemption from competitive bidding (carried forward from existing law) — no dollar threshold or oversight mechanism is specified, which is a standard accountability concern for any state health program
📊
Current Status
SB 1047 was introduced in the California Senate on February 12, 2026 by Senators Niello and Allen, with coauthors Senator Ochoa Bogh and Assembly Member Irwin.
As of the date of the bill text, the bill is at the introduced stage and has not yet been heard in committee. No votes have been taken.
Civic Action
Tools to act on what you've learned
Share this report
Take action
Upgrade
Coming soon
Pro
$9/month
- 📱SMS bill alertsText when your bills move
- 📄PDF exportPrint-ready decode, shareable offline
- 🔗Embed widgetLive decode card for your site
- ✉️Send your rep's emailOne click — we send it via Resend
- 📊Rep response tracker2-week follow-up: did they reply?
- 🔔Follow unlimited billsEmail + SMS status updates
API$99/mo
- ✓ Programmatic bill decode
- ✓ Bulk analysis
- ✓ JSON output
Decode another billDecoded by LegisPlain